BACKGROUND: Studies which have found that histologic features of metastatic melanoma in sentinel lymph nodes (SNs) were predictive of survival have differed considerably in their design and results. We investigated in detail the influence of SN tumor characteristics and clinical and primary tumor parameters on clinical outcomes in a large cohort of patients treated in a single center. METHODS: In SN-positive melanoma patients, the association of clinical, primary tumor, and SN tumor features [maximum size (MaxSize), % cross-sectional area of SN occupied by tumor (%CS), tumor-penetrative depth (TPD), intranodal location of tumor, extranodal spread (ENS), and perinodal lymphatic invasion (PLI)] with disease-free (DFS), distant metastasis-free (DMFS), and melanoma-specific (MSS) survival was analyzed. RESULTS: In 409 SN-positive patients, independent predictors of poorer DFS were primary tumor features [anatomic site: head/neck (HR = 3.65, 95% CI 1.65-8.08) and limbs (HR = 2.46, 95% CI 1.21-4.98) compared with trunk; ulceration (HR = 1.70, 95% CI 1.15-2.51); satellites (HR = 2.85, 95% CI 1.49-5.44)], SN tumor features [MaxSize (HR = 1.53, 95% CI 1.04-2.26); ENS in SN (HR = 2.05, 95% CI 1.06-4.00); PLI (HR = 1.85, 95% CI 1.11-3.07)], and positive CLND (HR = 1.92, 95% CI 1.26-2.91). Factors independently predictive of poorer MSS were age ≥50 years (HR 1.64, 95% CI 1.01-2.67), primary tumor features [ulceration (HR = 2.55, 95% CI 1.44-4.52); satellites (HR = 3.95, 95% CI 1.83-8.49)], and ENS in SN (HR = 2.34, 95% CI 1.06-5.13). CONCLUSIONS: The use of clinical, primary tumor, and SN tumor characteristics shown to be independent predictors of clinical outcomes in melanoma patients will assist in accurate prediction of prognosis and optimize clinical management.
BACKGROUND: Studies which have found that histologic features of metastatic melanoma in sentinel lymph nodes (SNs) were predictive of survival have differed considerably in their design and results. We investigated in detail the influence of SN tumor characteristics and clinical and primary tumor parameters on clinical outcomes in a large cohort of patients treated in a single center. METHODS: In SN-positive melanomapatients, the association of clinical, primary tumor, and SN tumor features [maximum size (MaxSize), % cross-sectional area of SN occupied by tumor (%CS), tumor-penetrative depth (TPD), intranodal location of tumor, extranodal spread (ENS), and perinodal lymphatic invasion (PLI)] with disease-free (DFS), distant metastasis-free (DMFS), and melanoma-specific (MSS) survival was analyzed. RESULTS: In 409 SN-positive patients, independent predictors of poorer DFS were primary tumor features [anatomic site: head/neck (HR = 3.65, 95% CI 1.65-8.08) and limbs (HR = 2.46, 95% CI 1.21-4.98) compared with trunk; ulceration (HR = 1.70, 95% CI 1.15-2.51); satellites (HR = 2.85, 95% CI 1.49-5.44)], SN tumor features [MaxSize (HR = 1.53, 95% CI 1.04-2.26); ENS in SN (HR = 2.05, 95% CI 1.06-4.00); PLI (HR = 1.85, 95% CI 1.11-3.07)], and positive CLND (HR = 1.92, 95% CI 1.26-2.91). Factors independently predictive of poorer MSS were age ≥50 years (HR 1.64, 95% CI 1.01-2.67), primary tumor features [ulceration (HR = 2.55, 95% CI 1.44-4.52); satellites (HR = 3.95, 95% CI 1.83-8.49)], and ENS in SN (HR = 2.34, 95% CI 1.06-5.13). CONCLUSIONS: The use of clinical, primary tumor, and SN tumor characteristics shown to be independent predictors of clinical outcomes in melanomapatients will assist in accurate prediction of prognosis and optimize clinical management.
Authors: Sojun Hoshimoto; Tatsushi Shingai; Donald L Morton; Christine Kuo; Mark B Faries; Kelly Chong; David Elashoff; He-Jing Wang; Robert M Elashoff; Dave S B Hoon Journal: J Clin Oncol Date: 2012-09-24 Impact factor: 44.544
Authors: Vera Teixeira; Ricardo Vieira; Inês Coutinho; Rita Cabral; David Serra; Maria José Julião; Maria Manuel Brites; Anabela Albuquerque; João Pedroso de Lima; Américo Figueiredo Journal: J Skin Cancer Date: 2013-12-25
Authors: Richard A Scolyer; Meagan J Judge; Alan Evans; David P Frishberg; Victor G Prieto; John F Thompson; Martin J Trotter; Maureen Y Walsh; Noreen M G Walsh; David W Ellis Journal: Am J Surg Pathol Date: 2013-12 Impact factor: 6.394
Authors: Pieter G L Koolen; Tiago R Matos; Ahmed M S Ibrahim; Jie Sun; Bernard T Lee; Robert A Frankenthaler; Samuel J Lin Journal: Plast Reconstr Surg Glob Open Date: 2017-07-12
Authors: K P Wevers; E Bastiaannet; H P A M Poos; R J van Ginkel; J T Plukker; H J Hoekstra Journal: Ann Surg Oncol Date: 2012-05-17 Impact factor: 5.344
Authors: Prisco Piscitelli; Cosimo Neglia; Andrea Falco; Matteo Rivezzi; Nadia Agnello; Alberto Argentiero; Giovanna Chitano; Chiara Distante; Giulia Della Rosa; Giorgia Vinci; Antonella De Donno; Alessandro Distante; Antonella Romanini Journal: Int J Environ Res Public Health Date: 2015-08-05 Impact factor: 3.390
Authors: Justin Rendleman; Shulian Shang; Christine Dominianni; Jerry F Shields; Patrick Scanlon; Christina Adaniel; Alexis Desrichard; Michelle Ma; Richard Shapiro; Russell Berman; Anna Pavlick; David Polsky; Yongzhao Shao; Iman Osman; Tomas Kirchhoff Journal: J Transl Med Date: 2013-11-04 Impact factor: 5.531